Logo image of B7J1.DE

SRV GROUP OYJ (B7J1.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:B7J1 - FI4000523675 - Common Stock

4.46 EUR
-0.09 (-1.98%)
Last: 12/11/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, B7J1 scores 3 out of 10 in our fundamental rating. B7J1 was compared to 41 industry peers in the Construction & Engineering industry. Both the profitability and financial health of B7J1 have multiple concerns. B7J1 is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year B7J1 has reported negative net income.
In the past year B7J1 had a positive cash flow from operations.
B7J1 had negative earnings in 4 of the past 5 years.
B7J1 had a positive operating cash flow in 4 of the past 5 years.
B7J1.DE Yearly Net Income VS EBIT VS OCF VS FCFB7J1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

The Return On Assets of B7J1 (0.29%) is worse than 84.44% of its industry peers.
B7J1 has a Return On Equity of 1.00%. This is amonst the worse of the industry: B7J1 underperforms 84.44% of its industry peers.
The Return On Invested Capital of B7J1 (0.69%) is worse than 86.67% of its industry peers.
Industry RankSector Rank
ROA 0.29%
ROE 1%
ROIC 0.69%
ROA(3y)-7.6%
ROA(5y)-5.78%
ROE(3y)-23.45%
ROE(5y)-19.55%
ROIC(3y)N/A
ROIC(5y)N/A
B7J1.DE Yearly ROA, ROE, ROICB7J1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

Looking at the Profit Margin, with a value of 0.21%, B7J1 is doing worse than 84.44% of the companies in the same industry.
B7J1 has a worse Operating Margin (0.44%) than 86.67% of its industry peers.
The Gross Margin of B7J1 (13.99%) is worse than 82.22% of its industry peers.
In the last couple of years the Gross Margin of B7J1 has grown nicely.
Industry RankSector Rank
OM 0.44%
PM (TTM) 0.21%
GM 13.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.34%
GM growth 5Y10.77%
B7J1.DE Yearly Profit, Operating, Gross MarginsB7J1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so B7J1 is destroying value.
Compared to 1 year ago, B7J1 has about the same amount of shares outstanding.
Compared to 5 years ago, B7J1 has more shares outstanding
Compared to 1 year ago, B7J1 has an improved debt to assets ratio.
B7J1.DE Yearly Shares OutstandingB7J1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
B7J1.DE Yearly Total Debt VS Total AssetsB7J1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

B7J1 has an Altman-Z score of 1.60. This is a bad value and indicates that B7J1 is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.60, B7J1 is doing worse than 64.44% of the companies in the same industry.
B7J1 has a debt to FCF ratio of 6.56. This is a slightly negative value and a sign of low solvency as B7J1 would need 6.56 years to pay back of all of its debts.
B7J1 has a Debt to FCF ratio (6.56) which is comparable to the rest of the industry.
B7J1 has a Debt/Equity ratio of 1.04. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of B7J1 (1.04) is worse than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 6.56
Altman-Z 1.6
ROIC/WACC0.11
WACC6.12%
B7J1.DE Yearly LT Debt VS Equity VS FCFB7J1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

B7J1 has a Current Ratio of 2.35. This indicates that B7J1 is financially healthy and has no problem in meeting its short term obligations.
B7J1 has a Current ratio of 2.35. This is amongst the best in the industry. B7J1 outperforms 93.33% of its industry peers.
A Quick Ratio of 0.75 indicates that B7J1 may have some problems paying its short term obligations.
The Quick ratio of B7J1 (0.75) is worse than 86.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 0.75
B7J1.DE Yearly Current Assets VS Current LiabilitesB7J1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

The earnings per share for B7J1 have decreased strongly by -300.00% in the last year.
The Revenue has decreased by -2.73% in the past year.
Measured over the past years, B7J1 shows a decrease in Revenue. The Revenue has been decreasing by -6.81% on average per year.
EPS 1Y (TTM)-300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-375%
Revenue 1Y (TTM)-2.73%
Revenue growth 3Y-7.18%
Revenue growth 5Y-6.81%
Sales Q2Q%-12.97%

3.2 Future

B7J1 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.09% yearly.
Based on estimates for the next years, B7J1 will show a small growth in Revenue. The Revenue will grow by 3.79% on average per year.
EPS Next Y-101.98%
EPS Next 2Y51.58%
EPS Next 3Y45.03%
EPS Next 5Y31.09%
Revenue Next Year-9.78%
Revenue Next 2Y-2.09%
Revenue Next 3Y1.91%
Revenue Next 5Y3.79%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
B7J1.DE Yearly Revenue VS EstimatesB7J1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
B7J1.DE Yearly EPS VS EstimatesB7J1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 -5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for B7J1. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 7.47, the valuation of B7J1 can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of B7J1 indicates a rather cheap valuation: B7J1 is cheaper than 93.33% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of B7J1 to the average of the S&P500 Index (24.01), we can say B7J1 is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 7.47
B7J1.DE Price Earnings VS Forward Price EarningsB7J1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80 -100

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of B7J1 indicates a rather cheap valuation: B7J1 is cheaper than 97.78% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.13
EV/EBITDA N/A
B7J1.DE Per share dataB7J1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

A more expensive valuation may be justified as B7J1's earnings are expected to grow with 45.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.58%
EPS Next 3Y45.03%

0

5. Dividend

5.1 Amount

B7J1 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SRV GROUP OYJ

FRA:B7J1 (12/11/2025, 7:00:00 PM)

4.46

-0.09 (-1.98%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)10-23 2025-10-23/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners26.31%
Inst Owner ChangeN/A
Ins Owners12.44%
Ins Owner ChangeN/A
Market Cap75.73M
Revenue(TTM)698.91M
Net Income(TTM)1.43M
Analysts37.5
Price Target5.03 (12.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-364.31%
Min EPS beat(2)-811.97%
Max EPS beat(2)83.36%
EPS beat(4)1
Avg EPS beat(4)-188.88%
Min EPS beat(4)-811.97%
Max EPS beat(4)83.36%
EPS beat(8)3
Avg EPS beat(8)-92.23%
EPS beat(12)4
Avg EPS beat(12)-242.29%
EPS beat(16)6
Avg EPS beat(16)60.16%
Revenue beat(2)0
Avg Revenue beat(2)-6.84%
Min Revenue beat(2)-8.5%
Max Revenue beat(2)-5.17%
Revenue beat(4)1
Avg Revenue beat(4)-4.66%
Min Revenue beat(4)-8.5%
Max Revenue beat(4)1.76%
Revenue beat(8)4
Avg Revenue beat(8)-2.09%
Revenue beat(12)4
Avg Revenue beat(12)-5.87%
Revenue beat(16)6
Avg Revenue beat(16)-4.62%
PT rev (1m)-0.26%
PT rev (3m)0.77%
EPS NQ rev (1m)-28.57%
EPS NQ rev (3m)-80%
EPS NY rev (1m)-150%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.47
P/S 0.11
P/FCF 3.13
P/OCF 2.54
P/B 0.53
P/tB 0.54
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)0.6
Fwd EY13.39%
FCF(TTM)1.42
FCFY31.93%
OCF(TTM)1.75
OCFY39.3%
SpS41.16
BVpS8.4
TBVpS8.22
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.29%
ROE 1%
ROCE 0.97%
ROIC 0.69%
ROICexc 0.87%
ROICexgc 0.88%
OM 0.44%
PM (TTM) 0.21%
GM 13.99%
FCFM 3.46%
ROA(3y)-7.6%
ROA(5y)-5.78%
ROE(3y)-23.45%
ROE(5y)-19.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.34%
GM growth 5Y10.77%
F-Score7
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 6.56
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.8%
Interest Coverage 0.38
Cash Conversion N/A
Profit Quality 1687.3%
Current Ratio 2.35
Quick Ratio 0.75
Altman-Z 1.6
F-Score7
WACC6.12%
ROIC/WACC0.11
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.38%
Cap/Sales(5y)0.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-375%
EPS Next Y-101.98%
EPS Next 2Y51.58%
EPS Next 3Y45.03%
EPS Next 5Y31.09%
Revenue 1Y (TTM)-2.73%
Revenue growth 3Y-7.18%
Revenue growth 5Y-6.81%
Sales Q2Q%-12.97%
Revenue Next Year-9.78%
Revenue Next 2Y-2.09%
Revenue Next 3Y1.91%
Revenue Next 5Y3.79%
EBIT growth 1Y-67.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-25.93%
EBIT Next 3Y19.43%
EBIT Next 5Y20.48%
FCF growth 1Y247.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y303.7%
OCF growth 3Y-82.57%
OCF growth 5YN/A

SRV GROUP OYJ / B7J1.DE FAQ

Can you provide the ChartMill fundamental rating for SRV GROUP OYJ?

ChartMill assigns a fundamental rating of 3 / 10 to B7J1.DE.


What is the valuation status of SRV GROUP OYJ (B7J1.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to SRV GROUP OYJ (B7J1.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for SRV GROUP OYJ?

SRV GROUP OYJ (B7J1.DE) has a profitability rating of 1 / 10.


How financially healthy is SRV GROUP OYJ?

The financial health rating of SRV GROUP OYJ (B7J1.DE) is 3 / 10.


How sustainable is the dividend of SRV GROUP OYJ (B7J1.DE) stock?

The dividend rating of SRV GROUP OYJ (B7J1.DE) is 0 / 10 and the dividend payout ratio is 0%.